tiprankstipranks
Trending News
More News >

Venus Medtech Announces Successful AGM Resolutions

Story Highlights
Venus Medtech Announces Successful AGM Resolutions

Don’t Miss TipRanks’ Half-Year Sale

The latest announcement is out from Venus Medtech (Hangzhou), Inc. Class H ( (HK:2500) ).

Venus Medtech (Hangzhou) Inc. announced that all resolutions proposed at its 2024 Annual General Meeting (AGM) were approved. The AGM, held on June 27, 2025, included the election of a new chairman and board members, re-appointment of auditors, and approval of the 2024 annual report and profit distribution plan. The successful passing of these resolutions reflects strong shareholder support and positions the company for continued governance and operational stability.

More about Venus Medtech (Hangzhou), Inc. Class H

Venus Medtech (Hangzhou) Inc. is a company incorporated in the People’s Republic of China, operating in the medical technology industry. It focuses on the development and commercialization of transcatheter heart valve products and related services.

Average Trading Volume: 3,177,973

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$1.16B

Learn more about 2500 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1